Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.

Elie A. Akl,Frederiek F. van Doormaal,Maddalena Barba,Ganga.J. Kamath,Seoyoung C. Kim,Saskia Kuipers,Saskia Middeldorp,Victor E D Yosuico,Heather O Dickinson,Holger J. Schünemann

Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.

2008

Elie A. Akl
Frederiek F. van Doormaal
Maddalena Barba
Ganga.J. Kamath
Seoyoung C. Kim
Saskia Kuipers
Saskia Middeldorp
Victor E D Yosuico
Heather O Dickinson
Holger J. Schünemann

Background To determine the efficacy and safety of heparin (unfractionated heparin (UFH) or low-molecular-weight-heparin (LMWH)) and fondaparinux in improving the survival of patients with cancer.

Keywords:

Randomized controlled trial
Cancer research
Heparin
Cancer
Oncology
Intensive care medicine
Fondaparinux
Lung cancer
Low molecular weight heparin
Hazard ratio
Survival analysis
Internal medicine
Medicine
Heparin.low molecular weight
non small cell
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations